Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer.
Karthik V GiridharCristobal SanhuezaDavid W HillmanHassan AlkhateebRachel CarlsonWinston TanBrian A CostelloFernando QuevedoLance PagliaroManish KohliPublished in: Prostate cancer and prostatic diseases (2018)
Elevated serum CGA was negatively associated with OS in men with mCRPC. Serum CGA represents a prognostic biomarker that may complement CTC enumeration.